WHEN:
Thursday, November 14th, 2024
4:00 PM - 8:00 PM EST

WHERE:
Northeastern University Innovation Campus
Building 5
147 S. Bedford Street
Burlington, MA 01803

PROGRAM DETAILS:
Cell & Gene Therapy: Distinct Challenges in Commercializing an Autologous Therapy
Cell and gene therapies have distinct differences from monoclonal antibodies and vaccines. Autologous cell and gene therapies add another element to the uniqueness of these therapies. This presentation will inform those new to the topic on some of these differences and dig into three challenges and how they were addressed for Bluebird bio’s LYFGENIA™.

Come to Northeastern University’s Burlington Campus for an opportunity to experience insightful presentations and Q&A on the cutting-edge field of Cell & Gene Therapy. There will be a short introductory “course” offered on the basics of C&G therapies and how they are developed. 

The main presentation will showcase industry experts delving into challenges they encountered while ensuring product quality and navigating regulatory landscapes crucial for bringing novel therapies to market. 

AGENDA:

4:00 PM - "Introduction to Cell & Gene Therapy" Session - OPTIONAL 101 Session for those new to the field
5:00 PM - Arrival, Networking, Welcome Appetizers, and Tour of Makers Space Facility*
6:00 PM - Introductions by Moderators and University Representative
6:15 PM - Speaker Presentations
7:00 PM - Q+A Session
7:20 PM - Networking and Refreshments

*Tours are member-only*

SPEAKERS:

REGISTRATION FEES:

Registration by EOD Wednesday, November 6, 2024
Members (Early Bird): $50
Non-Members (Early Bird): $95
Emerging Leaders Members (Early Bird): $20
Student Members: FREE

Registration Starting Thursday, November 7, 2024
Members: $60
Non-Members: $115
Emerging Leaders Members: $30
Student Members: $10 

**PLEASE NOTE: CANCELLATIONS RECEIVED ON/AFTER NOVEMBER 7 ARE SUBJECT TO BILLING**